Table 1. Treatment outcomes of percutaneous RFA in patients with cirrhosis.

Study	Year	No. of patients	Cirrhosis	Tumor size	Complete response	3-year survival	Complication rate
Brunello et al. (65)	2008	70	Mainly Child A	<3 cm	95.7%	63%	14.2% (all complications)
Lin et al. (66)	2005	62	Mainly Child A	<3 cm	92.8%	74%	4.8% (major complications)
Seror et al. (67)	2006	57	Child A only	<3.5 cm	–	91.2% (2-year)	15% (major complications)
Shiina et al. (68)	2005	118	Mainly Child A	<3 cm	100%	81%	5.1% (major complications)
Feng et al. (23)	2012	84	Mainly Child B	<3 cm	94%	67.2%	9.5% (all complications)
Liu et al. (26)	2016	100	Mainly Child A	Milan criteria	–	67.2%	11% (all complications)
Ng et al. (69)	2017	109	Mainly Child A	Milan criteria	94.4%	82.3%	4.6% (severe complications)